Evidence map›Paper›PMID 42553422›Full record

ArticleTherapeutic advances in gastroenterology2026

Pulmonary diffusion abnormalities in patients with inflammatory bowel disease: A longitudinal study.

Hugo Maisonneuve, Benedicte Caron, Anne Guillaumot, Mathias Poussel, David Sorel, François Chabot, Bruno Ribeiro Baptista, Laurent Peyrin-Biroulet, Ari Chaouat, Simon Valentin

Abstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hugo MaisonneuveDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
Benedicte CaronCHRU, Inserm, INFINY Institute, Université de Lorraine, Nancy, France.
Anne GuillaumotDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
Mathias PousselCHRU-Nancy, University Centre of Sports Medicine and Adapted Physical Activity, Nancy, France.
David SorelDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
François ChabotDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
Bruno Ribeiro BaptistaDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
Laurent Peyrin-BirouletCHRU, Inserm, INFINY Institute, Université de Lorraine, Nancy, France.ORCID https://orcid.org/0000-0003-2536-6618
Ari ChaouatDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.
Simon ValentinDépartement de Pneumologie, CHRU de Nancy, Pôle des Spécialités Médicales, Université de Lorraine, Nancy, France.ORCID https://orcid.org/0000-0002-9304-1359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Impaired diffusing capacity of the lung for carbon monoxide (DL Objectives: To describe the longitudinal report of prevalence and clinical characteristics of chronic DL Design: We conducted a prospective single-center study including consecutive patients with confirmed IBD and respiratory symptoms. Methods: Patients underwent longitudinal evaluation with chest CT scans and pulmonary function tests. Results: Among 75 patients with DL Conclusions: Chronic DL

Indexed as

inflammatory bowel diseaseslung physiologypulmonary function test

Identifiers

PMID42553422
PMCPMC13434094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.